Author: @paulkhls
Translation: Plain Language Blockchain
DeSci has been very hot recently, and today I want to share a bit about the current operation of DeSci and BioDAO, which comes from my speech at the Bangkok EFDevcon last week.
《DeSci Super Long Text》.
DeSci 2049 is a vision of future science, combining biotechnology with an unlicensed market driven by open science data and open access.
We know that Bitcoin has achieved an unlicensed currency, and ETH has achieved an unlicensed code.
Many of us invest in crypto-currencies to protect our autonomy and the freedoms that are being slowly and silently taken away.
A similar movement is forming in the fields of science and medicine, as our freedoms in innovation, self-experimentation, and the dissemination of science are being gradually eroded by a dysfunctional biomedical R&D system.
The current system lacks incentives to develop cures. Goldman Sachs once downgraded a biopharmaceutical company in 2018 for developing a cure for hepatitis C, questioning whether curing patients is a "sustainable business model".
The number of deaths from prescription opioid drugs is still rising. Our system needs lifetime consumers.
Scientists spend too much time looking for funding, rather than focusing on scientific research. Imagine if software developers spent most of their time looking for funding instead of writing code.
Most of the world's scientific talent has not been fully utilized. We have failed to realize a hopeful and prosperous solarpunk future because we have not upgraded the infrastructure of science and technology. This creates a world full of scientific friction, not scientific fantasy.
What if we could build an unlicensed world of science?
Self-sovereign science, defined as driven by open data and fluid markets, aimed at finding cures.
So, what roles do @Molecule_dao and @bioprotocol play in this?
Molecule is a protocol that puts scientific intellectual property on the chain
BIO is an engine that provides incubation and acceleration for on-chain science communities (BioDAOs), composed of scientists, patients, and investors
BioDAOs build knowledge assets (research, drugs, products) on the blockchain, focused on specific scientific domains or diseases.
For example, @vita_dao has funded several projects in the field of Longevity science and research, including the VITA-FAST project at @Vikorolchuk's lab @UniofNewcastle.
More information on VITA-FAST: https://vitafast.xyz
VITAFAST Token: https://coingecko.com/en/coins/molecules-of-korolchuk-ip-nft
Our team has helped build the first wave of BioDAOs, covering multiple scientific domains. When I gave this speech last week, the total market value of BioDAOs in our network was less than $100 million. Now it has exceeded $230 million!
Source: https://dune.com/kiba/bioconomy
BIO guides scientists, patients, and biotech founders through the process of on-chaining scientific communities, including Token economics, community building, financing, liquidity, and more.
BIO holders vote to onboard DAOs into the network - similar to a community-owned accelerator - allowing the best teams to stand out and launch their communities on-chain.
Upcoming projects will be launched on the BIO Launchpad, including @endrarediseases, @QuantumBioDAO, and @longcovidlabs.
Several new BioDAOs are focused on specific patient populations, seeking solutions and accelerating new approaches to cures.
Curetopia (@endrarediseases) targets the over $1 trillion rare disease space, led by @eperlste, a Y-Combinator alum, Harvard PhD, and rare disease entrepreneur, who has advanced a drug to Phase 3 clinical trials for only $5 million (far below the typical $100+ million cost).
https://x.com/bioprotocol/status/1842510500111741056/video/1
Long COVID Labs (@longcovidlabs) is accelerating cures for over 100 million patients globally, led by former Stanford neuroscientist @rd108, who self-treated his own Long COVID.
Today, @longcovidlabs is announcing the start of our first study using a combination antiviral treatment for general eligibility screening.
@QuantumBioDAO is developing quantum microscopes to observe quantum biological phenomena, led by MIT PhD @ClariceDAiello, who is a global leading quantum biologist:
Quantum Biology DAO's @geoffanders discussed the possibility of building quantum microscopes that could unlock the following innovations:
• Wearable devices to accelerate muscle recovery
• Mobile apps for cell therapy administration
• Efficient lab-grown meat production
Join @QuantumBioDAO: http://quantumbiology.community
Link to this article: https://www.hellobtc.com/kp/du/11/5540.html
Source: https://x.com/paulkhls/status/1858546224514941269
